LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 144

Search options

  1. Article: Professional medical education approaches: mobilizing evidence for clinicians.

    Lyu, Xiafei / Li, Sheyu

    Frontiers in medicine

    2023  Volume 10, Page(s) 1071545

    Abstract: Rapidly proliferating high-quality evidence supports daily decision-making in clinical practice. Continuing professional medical education links this evidence to practicing clinicians who are strongly motivated to improve the quality of their care by ... ...

    Abstract Rapidly proliferating high-quality evidence supports daily decision-making in clinical practice. Continuing professional medical education links this evidence to practicing clinicians who are strongly motivated to improve the quality of their care by using the latest information. Approaches to professional education vary, and their effects depend on specific scenarios. This narrative review summarizes the main approaches for professional medical education that facilitate the mobilization of evidence for clinicians. It includes traditional learning (passive and active dissemination of educational materials, lectures, and mass media dissemination), constructivist learning (engaging in local consensus processes and education outreach visits, interfacing with local opinion leaders, conducting patient-mediated interventions, employing audit and feedback processes, and utilizing clinical decision-supporting systems), and blended learning approaches (the integration of in-person or online passive learning with active and creative learning by the learners). An optimized selection from these approaches is challenging but critical to clinicians and healthcare systems.
    Language English
    Publishing date 2023-07-28
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2775999-4
    ISSN 2296-858X
    ISSN 2296-858X
    DOI 10.3389/fmed.2023.1071545
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Time-varying effects of sodium-glucose cotransporter-2 inhibitors in patients with heart failure: An updated meta-analysis.

    Zou, Xinyu / Shi, Qingyang / Li, Sheyu

    Journal of evidence-based medicine

    2024  Volume 17, Issue 1, Page(s) 13–16

    MeSH term(s) Humans ; Sodium-Glucose Transporter 2 Inhibitors/therapeutic use ; Heart Failure/drug therapy ; Diabetes Mellitus, Type 2/drug therapy ; Glucose ; Sodium
    Chemical Substances Sodium-Glucose Transporter 2 Inhibitors ; Glucose (IY9XDZ35W2) ; Sodium (9NEZ333N27)
    Language English
    Publishing date 2024-03-11
    Publishing country England
    Document type Meta-Analysis ; Letter
    ZDB-ID 2474496-7
    ISSN 1756-5391 ; 1756-5383
    ISSN (online) 1756-5391
    ISSN 1756-5383
    DOI 10.1111/jebm.12597
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: LEAP2: Next game-changer of pharmacotherapy for overweight and obesity?

    Liu, Dan / Li, Sheyu

    Cell reports. Medicine

    2022  Volume 3, Issue 4, Page(s) 100612

    Abstract: The world is seeking effective and safe weight-lowering drugs for centuries. LEAP2, acting on ghrelin and growth hormone secretagogue receptor, according to a study by Hageman et al. ...

    Abstract The world is seeking effective and safe weight-lowering drugs for centuries. LEAP2, acting on ghrelin and growth hormone secretagogue receptor, according to a study by Hageman et al.
    MeSH term(s) Humans ; Obesity/drug therapy ; Overweight/drug therapy ; Receptors, Ghrelin
    Chemical Substances Receptors, Ghrelin
    Language English
    Publishing date 2022-04-19
    Publishing country United States
    Document type News ; Comment
    ISSN 2666-3791
    ISSN (online) 2666-3791
    DOI 10.1016/j.xcrm.2022.100612
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Insights into the impact of sodium-glucose cotransporter 2 inhibition on urinary tract malignancy: A two-sample Mendelian randomization.

    Han, Zeyu / He, Yazhou / Li, Xue / Li, Sheyu / Ai, Jianzhong

    Diabetes, obesity & metabolism

    2024  Volume 26, Issue 5, Page(s) 1986–1989

    MeSH term(s) Humans ; Mendelian Randomization Analysis ; Hypoglycemic Agents ; Glucose ; Sodium ; Urologic Neoplasms ; Genome-Wide Association Study
    Chemical Substances Hypoglycemic Agents ; Glucose (IY9XDZ35W2) ; Sodium (9NEZ333N27)
    Language English
    Publishing date 2024-02-14
    Publishing country England
    Document type Letter
    ZDB-ID 1454944-x
    ISSN 1463-1326 ; 1462-8902
    ISSN (online) 1463-1326
    ISSN 1462-8902
    DOI 10.1111/dom.15490
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Partial Identification of Personalized Treatment Response with Trial-reported Analyses of Binary Subgroups.

    Li, Sheyu / Litvin, Valentyn / Manski, Charles F

    Epidemiology (Cambridge, Mass.)

    2023  Volume 34, Issue 3, Page(s) 319–324

    Abstract: Medical journals have adhered to a reporting practice that seriously limits the usefulness of published trial findings. Medical decision makers commonly observe many patient covariates and seek to use this information to personalize treatment choices. ... ...

    Abstract Medical journals have adhered to a reporting practice that seriously limits the usefulness of published trial findings. Medical decision makers commonly observe many patient covariates and seek to use this information to personalize treatment choices. Yet standard summaries of trial findings only partition subjects into broad subgroups, typically binary categories. Given this reporting practice, we study the problem of inference on long mean treatment outcomes E[y(t)|x], where t is a treatment, y(t) is a treatment outcome, and the covariate vector x has length K, each component being a binary variable. The available data are estimates of {E[y(t)|x k = 0], E[y(t)|x k = 1], P(x k )}, k = 1,..., K reported in journal articles. We show that reported trial findings partially identify {E[y(t)|x], P(x)}. Illustrative computations demonstrate that the summaries of trial findings in journal articles may imply only wide bounds on long mean outcomes. One can realistically tighten inferences if one can combine reported trial findings with credible assumptions having identifying power, such as bounded-variation assumptions.
    MeSH term(s) Humans ; Precision Medicine ; Patient Selection ; Treatment Outcome
    Language English
    Publishing date 2023-01-30
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1053263-8
    ISSN 1531-5487 ; 1044-3983
    ISSN (online) 1531-5487
    ISSN 1044-3983
    DOI 10.1097/EDE.0000000000001593
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Time-dependent risk of fracture in adults with type 2 diabetes receiving anti-diabetic drug: A one-stage network meta-analysis.

    Shen, Yanjiao / Shi, Qingyang / Zou, Xinyu / Meng, Wentong / Tian, Haoming / Du, Liang / Li, Sheyu

    Diabetes/metabolism research and reviews

    2024  Volume 40, Issue 2, Page(s) e3780

    Abstract: Aims: To assess the time-dependent risk of fracture in adults with type 2 diabetes receiving anti-diabetic drugs.: Materials and methods: We searched MEDLINE, EMBASE, and Cochrane Library up to 18 November 2021, for randomized controlled trials (RCTs) ...

    Abstract Aims: To assess the time-dependent risk of fracture in adults with type 2 diabetes receiving anti-diabetic drugs.
    Materials and methods: We searched MEDLINE, EMBASE, and Cochrane Library up to 18 November 2021, for randomized controlled trials (RCTs) and propensity-score-matched non-randomized studies (NRSs) comparing all anti-diabetic drugs with standard treatment or with each other on fracture in adults with type 2 diabetes. The study performed a one-stage network meta-analysis using discrete-time hazard regression with reconstructed individual time-to-event data.
    Results: This network meta-analysis involved seven RCTs (65,051 adults with type 2 diabetes) with a median follow-up of 36 months and three propensity-score-based NRSs (17,954 participants) with a median follow-up of 27.3 months. Among anti-diabetic drugs, thiazolidinediones increased the overall hazard of fracture by 42% (95% credible interval [CrI], 3%-97%) and almost tripled the risk after 4 years (hazard ratio [HR], 2.74; 95% CrI, 1.53-4.80). Credible subgroup analysis suggested that thiazolidinediones increased the hazard of fracture only in females (HR, 2.19; 95% CrI, 1.26-3.74) but not among males (HR, 0.81; 95% CrI, 0.45-1.40). Moderate certainty evidence established that thiazolidinediones increase 92 fractures in five years per 1000 female patients. We did not find the risk of fractures with other anti-diabetic drugs including metformin, sulfonylureas, sodium-glucose cotransporter-2 (SGLT2) inhibitors, and dipeptidyl peptidase-4 (DPP-4) inhibitors.
    Conclusions: Long-term use of thiazolidinediones elevates the risk of fracture among females with type 2 diabetes. There is no evidence eliciting fracture risk associated with other anti-diabetic drugs.
    MeSH term(s) Male ; Adult ; Female ; Humans ; Hypoglycemic Agents/adverse effects ; Network Meta-Analysis ; Diabetes Mellitus, Type 2/complications ; Diabetes Mellitus, Type 2/drug therapy ; Diabetes Mellitus, Type 2/chemically induced ; Dipeptidyl-Peptidase IV Inhibitors/adverse effects ; Fractures, Bone/epidemiology ; Fractures, Bone/etiology ; Fractures, Bone/prevention & control ; Thiazolidinediones/adverse effects
    Chemical Substances Hypoglycemic Agents ; Dipeptidyl-Peptidase IV Inhibitors ; Thiazolidinediones
    Language English
    Publishing date 2024-02-17
    Publishing country England
    Document type Meta-Analysis ; Journal Article
    ZDB-ID 1470192-3
    ISSN 1520-7560 ; 1520-7552
    ISSN (online) 1520-7560
    ISSN 1520-7552
    DOI 10.1002/dmrr.3780
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Mitochondrial energy metabolism in diabetic cardiomyopathy: Physiological adaption, pathogenesis, and therapeutic targets.

    Ye, Wanlin / Han, Kun / Xie, Maodi / Li, Sheyu / Chen, Guo / Wang, Yanyan / Li, Tao

    Chinese medical journal

    2024  Volume 137, Issue 8, Page(s) 936–948

    Abstract: Abstract: Diabetic cardiomyopathy is defined as abnormal structure and function of the heart in the setting of diabetes, which could eventually develop heart failure and leads to the death of the patients. Although blood glucose control and medications ... ...

    Abstract Abstract: Diabetic cardiomyopathy is defined as abnormal structure and function of the heart in the setting of diabetes, which could eventually develop heart failure and leads to the death of the patients. Although blood glucose control and medications to heart failure show beneficial effects on this disease, there is currently no specific treatment for diabetic cardiomyopathy. Over the past few decades, the pathophysiology of diabetic cardiomyopathy has been extensively studied, and an increasing number of studies pinpoint that impaired mitochondrial energy metabolism is a key mediator as well as a therapeutic target. In this review, we summarize the latest research in the field of diabetic cardiomyopathy, focusing on mitochondrial damage and adaptation, altered energy substrates, and potential therapeutic targets. A better understanding of the mitochondrial energy metabolism in diabetic cardiomyopathy may help to gain more mechanistic insights and generate more precise mitochondria-oriented therapies to treat this disease.
    MeSH term(s) Humans ; Diabetic Cardiomyopathies/metabolism ; Energy Metabolism/physiology ; Mitochondria/metabolism ; Animals
    Language English
    Publishing date 2024-03-25
    Publishing country China
    Document type Journal Article ; Review ; Research Support, Non-U.S. Gov't
    ZDB-ID 127089-8
    ISSN 2542-5641 ; 0366-6999 ; 1002-0187
    ISSN (online) 2542-5641
    ISSN 0366-6999 ; 1002-0187
    DOI 10.1097/CM9.0000000000003075
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Editorial: Community series in hepatic immune response underlying liver cirrhosis and portal hypertension, volume II.

    Lan, Tian / Li, Sheyu / Yu, Haopeng / Kostallari, Enis / Gao, Jinhang

    Frontiers in immunology

    2023  Volume 14, Page(s) 1305666

    MeSH term(s) Humans ; Liver Cirrhosis ; Hypertension, Portal/etiology
    Language English
    Publishing date 2023-10-11
    Publishing country Switzerland
    Document type Editorial ; Research Support, Non-U.S. Gov't
    ZDB-ID 2606827-8
    ISSN 1664-3224 ; 1664-3224
    ISSN (online) 1664-3224
    ISSN 1664-3224
    DOI 10.3389/fimmu.2023.1305666
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Pharmacotherapy for adults with overweight and obesity - Authors' reply.

    Shi, Qingyang / Wang, Yang / Li, Sheyu

    Lancet (London, England)

    2022  Volume 399, Issue 10341, Page(s) 2101

    MeSH term(s) Adult ; Humans ; Obesity/drug therapy ; Overweight/drug therapy
    Language English
    Publishing date 2022-06-03
    Publishing country England
    Document type Letter ; Comment
    ZDB-ID 3306-6
    ISSN 1474-547X ; 0023-7507 ; 0140-6736
    ISSN (online) 1474-547X
    ISSN 0023-7507 ; 0140-6736
    DOI 10.1016/S0140-6736(22)00786-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Precision medicine in cardiorenal and metabolic diseases with routinely collected clinical data: a novel insight.

    Li, Sheyu / Shi, Qingyang / Litvin, Valentyn / Manski, Charles F

    Precision clinical medicine

    2022  Volume 5, Issue 4, Page(s) pbac025

    Language English
    Publishing date 2022-09-24
    Publishing country England
    Document type Journal Article
    ZDB-ID 2948341-4
    ISSN 2516-1571 ; 2096-5303
    ISSN (online) 2516-1571
    ISSN 2096-5303
    DOI 10.1093/pcmedi/pbac025
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top